ArticleMolecular medicine reports2021

Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway.

Xiaoyan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.